CHE exerts a promising anticancer activity against ESC via the depletion of TAC with subsequent DNA damage, triggering the upregulation of the pro-apoptotic genes such as p53 and Bax. Moreover, CHE decreased the proliferative marker Ki67 and increased BAX protein in tumor tissues. The gene discussed is TP53; the disease is neoplasm.